Copeptin level differentiates takotsubo cardiomyopathy from acute myocardial infarction

Biomarkers. 2021 Mar;26(2):75-76. doi: 10.1080/1354750X.2021.1875503. Epub 2021 Jan 21.

Authors

Lukasz Szarpak^{1

2}, Aleksandra Gasecka^{3

4}, Mikołaj Opiełka⁴, Natasza Gilis-Malinowska⁵, Krzysztof J Filipiak³, Milosz J Jaguszewski⁵

Affiliations

¹ Maria Sklodowska-Curie Medical Academy in Warsaw, Warsaw, Poland.
² Białystok Oncology Centre, Białystok, Poland.
³ 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
⁴ Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
⁵ 1st Department of Cardiology, Medical University of Gdansk, Gdansk, Poland.

PMID: 33433256
DOI: 10.1080/1354750X.2021.1875503

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Glycopeptides
Humans
Myocardial Infarction* / diagnosis
ST Elevation Myocardial Infarction*
Takotsubo Cardiomyopathy* / diagnosis

Substances

Biomarkers
Glycopeptides
copeptins